As a partner of OneOncology, The Center for Cancer and Blood Disorders now has the ability to further its clinical trial offerings and oncology research knowledge by joining the launch of OneR. OneR is a national site management organization that brings operational expertise and centralized services to efficiently deliver multi-center clinical research across our growing network of community oncology practices.
OneR is a new unprecedented technology platform and collaboration. The network provides seamless clinical trial management, increased access to trial therapies for patients, and more oncology research information readily available to our clinicians. Patients can participate in clinical trials for specific cancer types, to decrease side effects of current treatments, or with aims to improve disease outcomes – and now, with the implementation of OneR, these efforts are supported more than ever before.
This new platform allows The Center to offer more clinical trials to patients in need by centralizing business functions, regulatory submissions, and clinical trial matching technology while also maintaining our flexibility to participate in other clinical trial initiatives managed by our Clinical Research Department. It’s an exciting time for cancer research, and this new initiative will give patients and their families more treatment options.